Mosquito-borne disease prevention
Generating evidence for an innovative and complementary vector control tool
The project, Advancing Evidence for the Global Implementation of Spatial Repellents (AEGIS) will build on decades of research and generate further evidence about an innovative new tool, spatial repellents, to help prevent vector-borne diseases like malaria and dengue. The AEGIS project is made possible thanks to Unitaid’s funding and support.
Beyond Bed Nets: Study Shows Consumers in Kenya Shopping for Alternative Mosquito Products
Learn more about JHU and KEMRI's retail audit findings and recent Malaria Journal publication.
Notre Dame and partners begin second spatial repellent trial for Unitaid-funded research program
The Mali trial has begun its baseline, which will last six months. Throughout this phase, the study team recruits participants and establishes the baseline of malaria infection.
Podcast: On Mosquito-Borne Diseases and Spatial Repellents
Nicole Achee, AEGIS Scientific Director, discusses mosquito-borne diseases and spatial repellent research on With a Side of Knowledge podcast
This project is made possible thanks to Unitaid funding and support. Unitaid is a global health agency engaged in finding innovative solutions to prevent, diagnose, and treat diseases more quickly, effectively, and for affordable prices, in low- and middle-income countries. Unitaid’s work includes funding initiatives to address major diseases such as HIV/AIDS, malaria, and tuberculosis, as well as HIV co-infections and co-morbidities such as cervical cancer and hepatitis C, and cross-cutting areas, such as fever management. Unitaid is now applying its expertise to address challenges in advancing new therapies and diagnostics for the COVID-19 pandemic, serving as a key member of the Access to COVID Tools Accelerator. Unitaid is hosted by the World Health Organization.
View AEGIS Consortium Members and Partners